| CXSL1500067 | 重组抗EGFR人鼠嵌合单克隆抗体注射液 | Recombinant anti-EGFR human-mouse chimeric monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2015-10-12 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2016-08-04 | view |
| CXSS1100005 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2011-07-18 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2016-08-01 | view |
| CXSL1200048 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2012-11-08 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2014-06-05 | view |
| CXSS1100021 | 重组抗CD20人鼠嵌合单克隆抗体注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2012-01-29 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2016-11-09 | view |
| CXSL1600034 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2016-06-15 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1100026 | 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(13) | New Drug Application | 2011-07-20 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2013-07-19 | view |
| CXSL1600035 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2016-06-15 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-01-17 | view |
